JPM 2026: Five takeaways on AI, M&A and outpatient growth

Enrollment on health insurance exchanges is declining for 2026 as premiums have risen sharply and government financial assistance has become less generous, reducing affordability for consumers. The trend portends lower covered lives and potential adverse selection pressures, creating headwinds for exchange participation and posing earnings and membership risks for insurers and managed-care providers while raising policy and political scrutiny of subsidy design.

Analysis

Market structure: Falling ACA exchange enrollment and shrinking subsidies create a bifurcated winners/losers market — large diversified insurers with heavy Medicare Advantage exposure (e.g., UNH, HUM) gain pricing power and stable premium pools, while pure-play individual/exchange carriers (e.g., OSCR, CNC’s exchange book) face revenue shrinkage and adverse selection. Expect consolidation pressure among smaller exchange carriers and rising medical-loss ratios for those retaining sicker cohorts; pricing power will tilt to scale players and vertically integrated PBMs/providers. Cross-asset: insurer equity volatility should rise near earnings; modest downward pressure on long-term yields is possible if federal subsidy outlays decline, while CPI risks tick up if providers pass cost through, creating two-way risk for fixed income and FX-hedged global healthcare exposure.

Risk assessment: Tail risks include rapid legislative relief (Congress restores subsidies within 60–120 days), state-level reinsurance expansion, or litigation forcing insurer rate rollbacks — each could flip short positions. Immediate (days) risk is headline-driven stock moves; short-term (weeks–months) risk centers on Q4 filings and CMS enrollment dumps; long-term (quarters/years) outcome depends on persistent subsidy policy and adverse selection dynamics. Hidden dependencies: employer plan uptake, Medicaid enrollment flows, and macro unemployment shifts can materially alter individual market size. Catalysts: CMS enrollment releases, midterm legislative calendar, and insurer rate filings over next 30–90 days.

Trade implications: Favor long large-cap diversified insurers (UNH, ELV) and short small-cap/exchange-exposed names (OSCR, CNC’s exchange segment) with a 3–12 month horizon; use pair trades to hedge market beta (long UNH / short OSCR). Use option structures to size asymmetric risk: buy 3–6 month put spreads on OSCR and CNC (limit risk to premium), and consider covered-call income on UNH to harvest elevated IV. Rotate away from small regional carriers and elective-procedure-exposed hospitals toward defensive healthcare staples (CVS) and Medicare Advantage beneficiaries; enter within 2–8 weeks ahead of CMS enrollment guidance and insurer earnings.

Contrarian angles: Consensus assumes uniform pain across insurers — that underestimates how MA exposure and PBM integration insulate margins, so UNH/ELV may be under-owned given these dynamics. Market may over-penalize all healthcare names; look for mispricings where exchange exposure is <20% of revenue. Historical parallel: 2017 subsidy uncertainty created transient drawdowns followed by consolidation and outperformance of scale players. Unintended consequence: aggressive shorts could be squeezed if policymakers reintroduce subsidies or state reinsurance reduces individual-market pressure.

Key Decisions for Investors

• Establish a 2–3% portfolio long in UNH (UnitedHealth) with a 6–12 month horizon to capture Medicare Advantage/scale-insurer resilience; layer in on any pullback of 5–10% and sell covered calls 3–6 months out to harvest IV.
• Initiate a 1–2% net short exposure to exchange-focused names: OSCR (Oscar Health) and CNC (Centene)’s individual-market segment (use equity shorts or buy 3–6 month put spreads sized to 1% portfolio risk each); set stop-loss at 8–10% adverse move and target 20–40% downside within 3–9 months if CMS enrollment decline persists.
• Buy protective 3–6 month put spreads on CNC and OSCR (e.g., buy 1× 15% OTM put, sell 1× 30% OTM put) sized so maximum premium = ~0.5–1% of portfolio per name to limit downside while retaining directional exposure.
• Reduce 1–2% exposure to small/mid-cap hospital operators (e.g., HCA risk-weighted) and redeploy into CVS (0.5–1%) and ELV (Elevance) (1–2%) for defensive, scale-insurer exposure; re-evaluate within 30–60 days following CMS enrollment and insurer Q4 filings.
• Monitor CMS 2026 exchange enrollment prints and state reinsurance announcements over next 30 days: if enrollment drop >5% year-over-year or multiple states expand reinsurance, accelerate shorts; conversely, if Congress signals subsidy restoration within 60 days, close shorts within 48 hours.